Prescription Drug Costs: Can Increased Competition Restrain Prices?

There is growing momentum among policymakers to address rising prescription drug prices. One approach is to use market forces to bring down costs by increasing competition through generics and biosimilars. During this webinar, panelists discussed opportunities and challenges in the generic and biosimilar market, how past administrations have approached this issue, and the impact on different stakeholders, including consumers.

This webinar is a project of the Alliance for Health Policy and NIHCM Foundation, in collaboration with the Association of Health Care Journalists.